Evidence map›Paper›PMID 33066162›Full record

ArticleBrain sciences2020

1,3,4-Oxadiazole Derivative Attenuates Chronic Constriction Injury Induced Neuropathic Pain: A Computational, Behavioral, and Molecular Approach.

Muhammad Faheem, Syed Hussain Ali, Abdul Waheed Khan, Mahboob Alam, Umair Ilyas, Muhammad Zahoor, Muhammad Umar Khayam Sahibzada, Sidra Khalid, Riaz Ullah, Ali S Alqahtani and 1 more

Open access · goldAbstract read
In one paragraph

Article in Brain sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 2 countries.

Muhammad FaheemRiphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad 44000, Pakistan.ORCID 0000-0001-8653-3817
Syed Hussain AliRiphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad 44000, Pakistan.
Abdul Waheed KhanDepartment of Pharmacy, The University of Lahore, Islamabad 44000, Pakistan.ORCID 0000-0001-6814-122X
Mahboob AlamDepartment of Pharmacy, Capital University of Science and technology, Islamabad 44000, Pakistan.
Umair IlyasRiphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad 44000, Pakistan.
Muhammad ZahoorDepartment of Biochemistry, University of Malakand, Chakdara, Dir (Lower), KP 23050, Pakistan.ORCID 0000-0002-4528-8517
Muhammad Umar Khayam SahibzadaDepartment of Pharmacy, Sarhad University of Science and Information Technology, Peshawar, KP 25000, Pakistan.ORCID 0000-0002-9768-4255
Sidra KhalidDepartment of Pharmacy, Faculty of Biological Sciences, Quaid-i-AzamUniversity, Islamabad 44000, Pakistan.
Riaz UllahDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0002-2860-467X
Ali S AlqahtaniDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0002-1034-7441
Abdulaziz M AlqahtaniDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
King Saud University · SARiphah International University · PKCapital University of Science and Technology · PKQuaid-i-Azam University · PKSarhad University of Science and Information Technology · PKUniversity of Lahore · PKUniversity of Malakand · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The production and up-regulation of inflammatory mediators are contributing factors for the development and maintenance of neuropathic pain. In the present study, the post-treatment of synthetic 1,3,4 oxadiazole derivative (B3) for its neuroprotective potential in chronic constriction injury-induced neuropathic pain was applied. In-silico studies were carried out through Auto Dock, PyRx, and DSV to obtain the possible binding and interactions of the ligands (B3) with COX-2, IL-6, and iNOS. The sciatic nerve of the anesthetized rat was constricted with sutures 3/0. Treatment with 1,3,4-oxadiazole derivative was started a day after surgery and continued until the 14th day. All behavioral studies were executed on day 0, 3rd, 7th, 10th, and 14th. The sciatic nerve and spinal cord were collected for further molecular analysis. The interactions in the form of hydrogen bonding stabilizes the ligand target complex. B3 showed three hydrogen bonds with IL-6. B3, in addition to correcting paw posture/deformation induced by CCI, attenuates hyperalgesia (

Indexed as

chronic constriction injuryhyperalgesiaIL-6In-siliconeuro-protective

Identifiers

PMID33066162
PMCPMC7601954
OpenAlexW3092906221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.